A generic pharmaceutical manufacturer, Glenmark Pharmaceuticals Inc. USA (Glenmark), located in Mahwah, New Jersey, has agreed to pay $25 million, based on its ability to pay, to resolve its alleged liability under the False Claims Act for conspiring to fix the price of a generic drug. Read More
Home » Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Pharmaceutical Company Pays $25M to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drug
Related Posts
Air Force Employee Pleads Guilty to Conspiracy to Disclose Unlawfully
A civilian employee of the U.S. Air Force assigned to the U.S. Strategic Command (USSTRATCOM) at Offutt Air Force Base pleaded guilty today to conspiring… BronAir Force Employee Pleads Guilty to Conspiracy to Disclose Unlawfully
Two Former West Virginia Correctional Officers Sentenced on Federal
Two former correctional officers from the Southern Regional Jail in Beaver, West Virginia, were sentenced today for their roles in an assault that resulted in… BronTwo Former West Virginia Correctional Officers Sentenced on Federal
Tennessee Man Pleads Guilty to COVID-19 Employee Retention Credit
A Tennessee man pleaded guilty to conspiring to commit wire and mail fraud, aiding and assisting in the preparation of a false tax return, and… BronTennessee Man Pleads Guilty to COVID-19 Employee Retention Credit